secwatch.observer — SEC 8-K summary
======================================

Issuer:     SkinHealth Systems Inc. (SKIN)
CIK:        0001818093
Form:       8-K
Filed at:   2023-11-13T23:59:59+00:00
Accession:  0001628280-23-038610
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BeautyHealth reports Q3 net loss of $73.8M, revises FY2023 guidance lower
-------------------------------------------------------------------------

- Net sales $97.4M (+10% YoY) but gross loss of $12.6M vs $61.4M profit a year ago; $63.1M restructuring charge for Syndeo device upgrades.
- Net loss $73.8M vs $0.1M loss prior year; adjusted EBITDA $9.1M (9.3% margin) down from $16.3M (18.4% margin).
- Revised FY2023 guidance: net sales $385-400M, adjusted EBITDA margin 5-6%; suspends long-term 2025 outlook.
- U.S. revenue weaker than expected; APAC and EMEA delivered double-digit growth; total delivery systems sold 2,140 vs 1,860.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818093/000162828023038610/0001628280-23-038610-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818093/000162828023038610/skin-20231113.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-038610

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer